DOI: 10.1055/s-00000075

Seminars in Respiratory and Critical Care Medicine

Issue 06 · Volume 28 · December 2007 DOI: 10.1055/s-002-8645 Optimizing Antimicrobial Therapy for Serious Infections in the Critically Ill David L Paterson M.D. Ph.D.

PREFACE

  • 575
    Paterson, David L.:

    Optimizing Antimicrobial Therapy for Serious Infections in the Critically Ill

  • 579
    Roberts, Jason A.; Lipman, Jeffrey:

    Optimizing Use of β-Lactam Antibiotics in the Critically Ill

  • 586
    Yang, Jenny C.; Tsuji, Brian T.; Forrest, Alan:

    Optimizing Use of Quinolones in the Critically Ill

  • 596
    Rea, Rhonda S.; Capitano, Blair:

    Optimizing Use of Aminoglycosides in the Critically Ill

  • 604
    Nation, Roger L.; Li, Jian:

    Optimizing Use of Colistin and Polymyxin B in the Critically Ill

  • 615
    Skrupky, Lee P.; Micek, Scott T.; Kollef, Marin H.:

    Optimizing Therapy for MRSA Pneumonia

  • 624
    Cosgrove, Sara E.; Fowler, Vance G.:

    Optimizing Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia

  • 632
    Linden, Peter K.:

    Optimizing Therapy for Vancomycin-Resistant Enterococci (VRE)

  • 646
    Endimiani, Andrea; Paterson, David L.:

    Optimizing Therapy for Infections Caused by Enterobacteriaceae Producing Extended-Spectrum β-Lactamases

  • 656
    Iredell, Jonathan R.:

    Optimizing Antipseudomonal Therapy in Critical Care

  • 662
    Peleg, Anton Y.:

    Optimizing Therapy for Acinetobacter baumannii

  • 672
    Muder, Robert R.:

    Optimizing Therapy for Stenotrophomonas maltophilia

  • 678
    Playford, Elliott Geoffrey; Sorrell, Tania C.:

    Optimizing Therapy for Candida Infections